Pharmacological intervention for dengue virus infection

Area of Science:

• Virology
• Infectious Diseases
• Tropical Medicine

Background:

• Dengue virus (DENV) infection poses a significant global health threat, particularly in tropical and subtropical regions.
• Severe dengue manifestations, such as dengue hemorrhagic fever and dengue shock syndrome, lead to substantial morbidity and mortality.
• Current DENV vaccines have limitations, highlighting the urgent need for effective antiviral treatments.

Purpose of the Study:

• To review current approaches for identifying anti-DENV medications.
• To discuss recent advancements in potential DENV-targeting compounds and clinical trial experiences.
• To provide guidance on selecting and developing better anti-DENV treatment strategies.

Main Methods:

• Literature review of anti-DENV medication development.
• Analysis of clinical trial data for dengue treatments.
• Evaluation of challenges and future directions in DENV therapy.

Main Results:

• Several approaches exist for identifying anti-DENV medications, with ongoing research into novel compounds.
• Clinical trials have shown mixed results, facing challenges related to efficacy, safety, and patient stratification.
• Understanding reasons for treatment failure is key to refining therapeutic strategies.

Conclusions:

• There is a critical need for effective and tolerable DENV medications for early-phase treatment and management of severe cases.
• Further research and strategic development are required to overcome challenges and select optimal anti-DENV therapies.
• This review offers guidance for clinicians and researchers in combating DENV infection.